Addressing Protection of Human Subjects in PCORI Applications and Merit Review
About Us
- 2023 Annual Meeting
- About PCORI
- The PCORI Strategic Plan
- Governance
- Evaluating Our Work
- PCORI's Advisory Panels
- Procurement Opportunities
-
Provide Input
-
Past Opportunities to Provide Input
- Stakeholder Views on Components of 'Patient-Centered Value' in Health and Health Care (2023)
- PCORI's Proposed Research Agenda (2021-2022)
- Proposed National Priorities for Health (2021)
- Proposed Principles for the Consideration of the Full Range of Outcomes Data in PCORI-Funded Research (2020)
- Proposed New PCORI Methodology Standards (2018)
- Data Access and Data Sharing Policy: Public Comment (2017)
- Proposed New PCORI Methodology Standards (2017)
-
Comment on the Proposed New and Revised PCORI Methodology Standards (2016)
- 1. Standards for Formulating Research Questions
- 10: Standards for Studies of Diagnostic Tests
- 12. Standards on Research Designs Using Clusters
- 13: General Comments on the Proposed Revisions to the PCORI Methodology Standards
- 2: Standards Associated with Patient-Centeredness
- 3: Standards for Data Integrity and Rigorous Analysis
- 4: Standards for Preventing and Handling Missing Data
- 5: Standards for Heterogeneity of Treatment Effects
- 6: Standards for Data Registries
- 7: Standards for Data Networks as Research-Facilitating Structures
- 8. Standards for Causal Inference Methods
- 9. Standards for Adaptive Trial Designs
- Peer-Review Process Comments (2014)
- Draft Methodology Report Public Comment Period (2012)
-
Past Opportunities to Provide Input
- Leadership
At PCORI, we are always working to improve the way we do our work. As part of that work, we are now providing additional guidance and resources for applicants and reviewers to ensure that applications for our research funding and review of applications appropriately address the protection of human subjects.
Roots in the Common Rule
PCORI expects research that we fund to comply with the US Department of Health and Human Services’ (HHS) Federal Policy for the Protection of Human Subjects, reflected in HHS regulation 45 CFR 46. This regulation includes the Common Rule, which outlines the basic provisions for establishment and functioning of institutional review boards (IRBs) and requirements for informed consent of human research subjects. We also rely on National Institutes of Health (NIH) guidance and its interpretation of the Common Rule. We understand, of course, that many of our awardees are also funded by federal agencies and that some institutions already extend Common Rule and other federal protections to all research conducted at their institutions, federally funded or not.
Information for Applicants
PCORI’s Application Guidelines now include more comprehensive information on how PCORI expects applicants for PCORI research funding to address human subjects protections. Specifically, we designate up to five pages in the Research Plan where applicants may describe how they propose to protect human subjects in their research. PCORI requires that all applicants adhere to the NIH policy on the protection of human subjects in research, including the requirement that all key personnel on PCORI applications complete human subjects training, which may be fulfilled through the NIH Protecting Human Research Participants training tutorial or another program. More information about the training requirement and resources can be found on the NIH website.
Information for Merit Reviewers
For merit reviewers who will be participating in the review of applications for PCORI funding, we have created a new How to Evaluate Human Subjects Protections checklist to help them identify relevant issues relating to human subjects protections that they may see in applications. Researchers also might find the checklist helpful in developing their description of human subjects protections in their applications.
The checklist outlines four topics relating to human subjects protection for merit reviewers to keep in mind as they review applications:
- Potential risk to human subjects
- Adequacy of protections against risks
- Potential benefits of the proposed research
- Importance of the knowledge to be gained.
If human subjects protections issues are identified by reviewers in applications being considered for funding, PCORI staff can work with potential awardees to address those issues.
This updated guidance for applicants and reviewers is designed to support the quality of research funded by PCORI and the experience of study participants. Protection of human subjects is integral to our mission to produce high-quality, useful health information. We welcome your thoughts on our efforts. Please contact us to share your ideas.
Note: This page was changed on May 13, 2016, to indicate that our requirement for human subjects protection training can be fulfilled by either the NIH Protecting Human Research Participants training tutorial or another program.
Tags
Comments
June 9, 2016, 9:23 PM
Comment by PCORI,
June 5, 2016, 1:00 PM
Comment by Samuel kazungu,
What is the order of importance between ethics and legality in conducting clinical research?
What's Happening at PCORI?
The Patient-Centered Outcomes Research Institute sends weekly emails about opportunities to apply for funding, newly funded research studies and engagement projects, results of our funded research, webinars, and other new information posted on our site.
Image

Thank you for your comment, Samuel. This is a complex question, but our general sense is that the legal framework that has been developed for the conduct of clinical research is itself an ethical framework because it translates ethical principles into legal requirements. Additional information can be found at the following sources: http://ctj.sagepub.com/content/early/2015/08/24/1740774515598334 | http://www.hhs.gov/ohrp/regulations-and-policy/regulations/45-cfr-46/in… | http://bioethics.gov/node/558